Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gravel, CA

Anick Gravel, Vaudreuil Dorion CA

Patent application numberDescriptionPublished
20080259945Communication circuit for a vehicle - A communication circuit for use within a vehicle includes a first network port and a second network port that is remotely located from the first network port. The networks are digitally connected together and digitally communicate a signal therebetween. The communication circuit is used between two or more coupled train vehicles.10-23-2008

Bernard Gravel, Kirkland CA

Patent application numberDescriptionPublished
20100183447DIGITAL OVER SPEED CIRCUIT - The present embodiments relate to a digital over speed circuit including a controller configured to calculate the speed of an engine and shut down the engine electronically when an over speed condition exists. The digital over speed circuit may be easily installed by the end user. Only a single wire is needed between the digital over speed circuit and the engine. Further, the digital over speed circuit does not require a reset or any user action of any kind after the over speed condition has been detected and power removed from the engine. In other words, there is no ON switch, and the user may immediately start the engine again after the engine has stopped and the digital over speed circuit has reset.07-22-2010

Claude Gravel, Quebec CA

Patent application numberDescriptionPublished
20110315171WASHER CHAMBER PRESSURE-RELIEF ASSEMBLY - A pressure-relief assembly for adjusting pressure within a washing chamber of a washer.12-29-2011

Denis Gravel, Saintlambert CA

Patent application numberDescriptionPublished
20090253623GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.10-08-2009

Denis Gravel, Saint-Lambert CA

Patent application numberDescriptionPublished
20090011985GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.01-08-2009
20090088383GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.04-02-2009
20090176869Halogenated Rhodamine Derivatives and Applications Thereof - Compounds of formula I:07-09-2009
20100087366GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.04-08-2010
20110021616HALOGENATED RHODAMINE DERIVATIVES AND APPLICATIONS THEREOF - Methods for treating a bacterial infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with bacteria. A rhodmaine compound is mixed with the infected tissue sample to form a mixture. The mixture is then exposed to radiant energy to inhibit or kill the bacteria. The exposed mixture is then transplanted into the patient. Examples of rhodamine compounds include 2′-(6-dimethylamino-3-dimethylimino-3H-xanthen-9-yl) 4′, 5′-dichloro-benzoic acid methyl ester hydrochloride; 4,5-dibromorhodamine 110 2-(2-methoxy ethoxy)ethyl ester hydrobromide; acetate salt of 2,7-dibromorhodamine B hexyl ester; acetate salt of 2,7-dibromorhodamine B methyl ester; 4,5-dibromorhodamine 6G hydrobromide; rhodamine B 3-bromopropyl; acetate salt of 2,7-dibromo-4′-carboxytetramethylrosamine methyl ester; 4-bromo-5-phenyl rhodamine B methyl ester chloride; 2,7-dibromo-4,5-dimethyl rhodamine B methyl ester bromide; 2-bromo-7-ethynyl rhodamine B methyl ester bromide; and 4,5-dibromo-2,7-di-n-butyl rhodamine B methyl ester bromide.01-27-2011

Patent applications by Denis Gravel, Saint-Lambert CA

Jean-Francois Gravel, Stoneham CA

Patent application numberDescriptionPublished
20110226962METHOD AND APPARATUS FOR DETECTING FLUORESCENCE EMITTED BY PARTICLE-BOUND FLUOROPHORES CONFINED BY PARTICLE TRAPS - A method of detecting a fluorescence signal emitted by fluorophores bound to particles confined in a particle trap, includes an objective lens having a focal plane, which is normally the focal plane for incident collimated light. The particle trap is typically located in the focal plane, and a beam of excitation light is directed via the objective lens onto the confined particles in the trap. The excitation light is in the form of a divergent beam coming to focus at a plane displaced from the focal plane. The divergent beam has a spot diameter at the focal plane determined by the divergence of the beam. The fluorescent light emitted by the fluorophores is detected with a confocal detector.09-22-2011

Martin Gravel, Chicoutimi CA

Patent application numberDescriptionPublished
20110071002REHABILITATION SYSTEM AND METHOD USING MUSCLE FEEDBACK - There is provided a machine for rehabilitation or exercise, comprising: a frame; a first arm movably secured to the frame via a first actuator; a first force sensor for measuring a force exerted by a user on the first arm; and a control unit adapted for controlling a displacement speed for the first arm via the first actuator as a function of the force and for increasing the displacement speed of the first arm via the first actuator when the force is superior to a target force. In one embodiment, there is further provided an electromyograph for location on the exercised muscle for measuring an electrical potential generated by the muscle and for lowering the target force when the electrical potential is superior to a predetermined maximum electrical potential. There is further provided a method for operating an exercise machine and a system for exercising a muscle.03-24-2011

Vivianne Gravel, Longueuil CA

Patent application numberDescriptionPublished
20110197267SECURE AUTHENTICATION SYSTEM AND METHOD - There is disclosed a system and method for authenticating the identity of a user of a client device as part of a transaction between the client device and a server of a service provider over a communications network, the client device comprising a unique identifier. The system and method comprise one or more personal identification elements issued to the user based upon an initial authentication of the identity of the user, a credential issued to the client device by the service provider based upon the personal identification elements and the unique identifiers, and a trigger event for launching an authentication application installed on the client device. When the authentication application is launched by the trigger event, the authentication application transmits the one or more personal identification elements and the unique identifier in a combination with the credential to the server for authentication by the service provider.08-11-2011